Navigation Links
Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
Date:3/10/2010

REDWOOD CITY, Calif., March 10 /PRNewswire/ -- Codexis, Inc. today announced that Vonnie Estes has joined the company as Vice President, Strategic Planning, Technology.  In this new position, Ms. Estes will be responsible for moving Codexis' technical developments to commercial applications.  She will report to David Anton, Ph.D., Senior Vice President, Research and Development.

Ms. Estes brings Codexis two decades of experience leading product and commercial development programs for global chemical companies, most recently focusing on biofuels. She joins Codexis from DuPont Danisco Cellulosic Ethanol, where she was Vice President, Commercial Development. Previously, she was New Venture Manager, Cellulosic Biofuels for DuPont Advanced Biofuels, where she helped create the commercialization strategy for the DuPont cellulosic ethanol technology.  She also held business development management positions at various companies including Monsanto and Syngenta.  Ms. Estes holds a Bachelor of Science degree from the University of New Mexico and a Master of Science degree in plant pathology from the University of California, Davis.

"Vonnie Estes is a talented and experienced professional with a proven track record in successful development and commercialization of new technology," Dr. Anton said.  "She combines experience from major global corporations and entrepreneurial startups, and will play an important role in commercialization of our technical portfolio and strategy.  We are delighted to welcome her to Codexis."

Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale.  Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals. 

Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.

SOURCE Codexis, Inc.

Back to top

RELATED LINKS
http://www.codexis.com

'/>"/>

SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Appoints Singapore Laboratories Managing Director
2. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
3. Bruce Pasternack Elected to Codexis Board
4. Codexis Opens Singapore Laboratory
5. Rothwell, Wolf Elected to Codexis Board
6. Codexis Launches Codex(TM) MicroCyp Platform to Produce Drug Metabolites and Novel Lead Compounds
7. Codexis Names David Anton VP Bioindustrials R&D
8. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
9. Codexis, Arch Announce Expanded Collaboration
10. Codexis Names Vice President, Intellectual Property
11. Codexis, Teva in Licensing Agreement Final
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or ... is excited to announce the formation of EyGen, ... preclinical ophthalmology assets through proof of concept. EyGen,s ... by Portage Pharmaceuticals Limited and being developed for ... and anterior segment diseases. This agent has the ...
(Date:11/30/2016)... /PRNewswire/ -  Equicare Health Inc ., the leading supplier ... one of the top 100 companies in the 2016 ... distinguishes the top digital health companies across the globe. ... this year continually upgrading our product with the ongoing ... team," says Len Grenier , CEO of Equicare ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
(Date:11/30/2016)... , ... November 30, 2016 , ... SSCI, the established ... discuss the implications of the latest FDA guidance on pharmaceutical cocrystals as drug ... in Cambridge, MA. , The event follows the successful November 15th event ...
Breaking Biology Technology:
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
Breaking Biology News(10 mins):